Filters
Sort results
Reset
Apply
Cat No. | Products Name | Name | Previous Name | Target | Format | Options | Order | quote |
|---|---|---|---|---|---|---|---|---|
Pre-Made Lupartumab Amadotin Biosimilar, Whole Mab Adc, Anti-Lypd3 Antibody: Anti-C4.4A therapeutic antibody Drug Conjugate |
lupartumab amadotin |
NA |
LYPD3 |
Whole mAb ADC |
||||
Pre-Made Luspatercept Biosimilar, Fusion Protein targeting GDF11 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting BMP-11/BMP11/VHO |
luspatercept |
NA |
GDF11 |
Fusion Protein |
||||
Pre-Made Lutetium (177Lu) Lilotomab Satetraxetan Biosimilar, Radiolabelled Antibody, Anti-Cd37 Antibody: Anti-GP52-40/TSPAN26 therapeutic antibody |
lutetium (177lu) lilotomab satetraxetan |
NA |
CD37 |
Radiolabelled antibody |
||||
Pre-Made Mapatumumab Biosimilar, Whole Mab, Anti-TNFRSF10A/TRAIL-R1 Antibody: Anti-APO2/CD261/DR4/TRAILR-1/TRAILR1 therapeutic antibody |
mapatumumab |
NA |
TNFRSF10A |
Whole mAb |
||||
Pre-Made Maslimomab Biosimilar, Whole Mab: Anti-T Cell Receptor (Tr, Tr Alpha_Beta) [human] therapeutic antibody |
maslimomab |
NA |
T cell receptor (TR, TR alpha_beta) [Homo sapiens] |
Whole mAb |
||||
Pre-Made Melredableukin Alfa Biosimilar, Fusion Protein targeting IL2RA fused with human IL2 (interleukin 2, IL-2) via a peptidyl linker: Recombinant therapeutic protein targeting CD25/IDDM10/IL2R/IM |
melredableukin alfa |
NA |
IL2RA |
Fusion Protein |
||||
Pre-Made Metelimumab Biosimilar, Whole Mab, Anti-Tgfb1 Antibody: Anti-CED/DPD1/IBDIMDE/LAP therapeutic antibody |
metelimumab |
NA |
TGFB1 |
Whole mAb |
||||
Pre-Made Minretumomab Biosimilar, Whole Mab: Anti-Tag-72 therapeutic antibody |
minretumomab |
NA |
TAG-72 |
Whole mAb |
||||
Pre-Made Mipasetamab Uzoptirine Biosimilar, Whole Mab Adc, Anti-Axl Antibody: Anti-ARK/JTK11/Tyro7/UFO therapeutic antibody Drug Conjugate |
mipasetamab uzoptirine |
NA |
AXL |
Whole mAb ADC |
||||
Pre-Made Mirococept biosimilar, Recombinant Protein targeting C3b/C4b: Recombinant therapeutic protein |
mirococept |
NA |
C3b/C4b |
Recombinant Protein |
||||
Pre-Made Mirvetuximab Soravtansine Biosimilar, Whole Mab Adc, Anti-Folr1 Antibody: Anti-FBP/FOLR/FRalpha/NCFTD therapeutic antibody Drug Conjugate |
mirvetuximab soravtansine |
NA |
FOLR1 |
Whole mAb ADC |
||||
Pre-Made Mirzotamab Clezutoclax Biosimilar, Whole Mab Adc, Anti-Cd276 Antibody: Anti-4Ig-B7-H3/B7-H3/B7H3/B7RP-2 therapeutic antibody Drug Conjugate |
mirzotamab clezutoclax |
NA |
CD276 |
Whole mAb ADC |
||||
Pre-Made Mitumomab Biosimilar, Whole Mab: Anti-Ganglioside Gd3 therapeutic antibody |
mitumomab |
NA |
ganglioside GD3 |
Whole mAb |
||||
Pre-Made Modakafusp Alfa Biosimilar, Fusion Protein targeting CD38 fused with human IFNA2 (interferon alpha 2) *b (R46,H57) 24-188: Recombinant therapeutic protein targeting ADPRC 1/ADPRC1 |
modakafusp alfa |
NA |
CD38 |
Fusion Protein |
||||
Pre-Made Morolimumab Biosimilar, Whole Mab, Anti-Rhd Antibody: Anti-CD240D/DIIIc/HDFNRH/RH/RH30/RHCED/RHDVA(TT)/RHDel/RHPII/RHXIII/Rh4/RhDCw/RhII/RhK562-II/RhPI therapeutic antibody |
morolimumab |
NA |
RHD |
Whole mAb |
||||
Pre-Made Moxetumomab Pasudotox biosimilar, Fusion Protein, Moxetumomab-Anti-CD22 Antibody: Anti-SIGLEC-2/SIGLEC2 therapeutic antibody fused with Pseudomonas aeruginosa exotoxin A |
moxetumomab pasudotox |
NA |
CD22 |
Fusion Protein |
||||
Pre-Made Muromonab-Cd3 3Iosimilar, Whole Mab, Anti-Cd3E Antibody: Anti-CD3epsilon/IMD18/T3E/TCRE therapeutic antibody |
muromonab-CD3 |
NA |
CD3E |
Whole mAb |
||||
Pre-Made Nacolomab Tafenatox biosimilar, Fusion Protein, Nacolomab-Anti-MUC1 Antibody: Anti-ADMCKD/ADMCKD1/ADTKD2/CA 15-3/CD227/Ca15-3/EMA/H23AG/KL-6/MAM6/MCD/MCKD/MCKD1/SEC/X/ZD/PEM/PEMT/PUM therape |
nacolomab tafenatox |
NA |
MUC1 |
Fusion Protein |
||||
Pre-Made Naptumomab Estafenatox biosimilar, Fusion Protein, Naptumomab-Anti-TPBG Antibody: Anti-5T4/5T4AG/M6P1/WAIF1 therapeutic antibody fused with Staphylococcus aureus enterotoxin E SEA/E120 super |
naptumomab estafenatox |
NA |
TPBG |
Fusion Protein |
||||
Pre-Made Naratuximab Emtansine Biosimilar, Whole Mab Adc, Anti-Cd37 Antibody: Anti-GP52-40/TSPAN26 therapeutic antibody Drug Conjugate |
naratuximab emtansine |
NA |
CD37 |
Whole mAb ADC |
